1-year results of combined half-dose photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy

被引：0
|
作者：
Ian Y. Wong
Xuan Shi
Rita Gangwani
Paul Zhao
Lawrence P. Iu
Qing Li
Alex Ng
Xiaoxin Li
机构：
[1] The University of Hong Kong,Department of Ophthalmology, LKS Faculty of Medicine
[2] Peking University People’s Hospital,Department of Ophthalmology
[3] National University Hospital,Department of Ophthalmology
来源：
BMC Ophthalmology | / 15卷
关键词：
Age related macular degeneration; Half-dose; Half-fluence; Photodynamic therapy; Polypoidal choroidal vasculopathy; Ranibizumab; Verteporfin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Treatment results at 1 year of ranibizumab therapy for polypoidal choroidal vasculopathy in eyes with good visual acuity
    Ryusaburo Mori
    Mitsuko Yuzawa
    Eriko Akaza
    Miho Haruyama
    Japanese Journal of Ophthalmology, 2013, 57 : 365 - 371
  • [42] Photodynamic Therapy for Polypoidal Choroidal Vasculopathy
    Chhablani, Jay Kumar
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2010, 150 (05) : 754 - 755
  • [43] Factors influencing the outcome of polypoidal choroidal vasculopathy following combined treatment with photodynamic therapy and intravitreal ranibizumab
    Tan, C. S.
    Ngo, W. K.
    Lim, L. W.
    Lim, T. H.
    EYE, 2015, 29 (09) : 1238 - 1238
  • [44] Photodynamic therapy for polypoidal choroidal vasculopathy
    Jay Kumar Chhablani
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2011, 249 : 791 - 791
  • [45] Photodynamic therapy of polypoidal choroidal vasculopathy
    Rogers, AH
    Greenberg, PB
    Martidis, A
    Puliafito, CA
    OPHTHALMIC SURGERY LASERS & IMAGING, 2003, 34 (01): : 60 - 63
  • [46] Photodynamic Therapy for Polypoidal Choroidal Vasculopathy
    Chhablani, Jay Kumar
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2010, 26 (05) : 529 - 529
  • [47] Photodynamic therapy for polypoidal choroidal vasculopathy
    Chhablani, Jay Kumar
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2011, 249 (05) : 791 - 791
  • [48] INTRAVITREAL RANIBIZUMAB WITH OR WITHOUT PHOTODYNAMIC THERAPY FOR THE TREATMENT OF SYMPTOMATIC POLYPOIDAL CHOROIDAL VASCULOPATHY
    Lai, Timothy Y. Y.
    Lee, Gary K. Y.
    Luk, Fiona O. J.
    Lam, Dennis S. C.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (08): : 1581 - 1588
  • [49] Reduced-Fluence Photodynamic Therapy in Polypoidal Choroidal Vasculopathy Nonresponsive to Ranibizumab
    Byon, Ik Soo
    Kwon, Han Jo
    Kim, Sung Il
    Shin, Min Kyu
    Park, Sung Who
    Lee, Ji Eun
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2014, 45 (06): : 534 - 541
  • [50] Comparison of two-year outcomes after photodynamic therapy with ranibizumab or aflibercept for polypoidal choroidal vasculopathy
    Kikushima, Wataru
    Sakurada, Yoichi
    Sugiyama, Atsushi
    Yoneyama, Seigo
    Tanabe, Naohiko
    Matsubara, Mio
    Mabuchi, Fumihiko
    Iijima, Hiroyuki
    SCIENTIFIC REPORTS, 2017, 7
12345